Cargando…
Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin
BACKGROUND: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) can be used to treat heart diseases; however, the optimal maturity of hiPSC-CMs for effective regenerative medicine remains unclear. We aimed to investigate the benefits of long-term cultured mature hiPSC-CMs in injur...
Autores principales: | Tanaka, Yuki, Kadota, Shin, Zhao, Jian, Kobayashi, Hideki, Okano, Satomi, Izumi, Masaki, Honda, Yusuke, Ichimura, Hajime, Shiba, Naoko, Uemura, Takeshi, Wada, Yuko, Chuma, Shinichiro, Nakada, Tsutomu, Tohyama, Shugo, Fukuda, Keiichi, Yamada, Mitsuhiko, Seto, Tatsuichiro, Kuwahara, Koichiro, Shiba, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486094/ https://www.ncbi.nlm.nih.gov/pubmed/37679796 http://dx.doi.org/10.1186/s13287-023-03468-4 |
Ejemplares similares
-
Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo
por: Ichimura, Hajime, et al.
Publicado: (2020) -
Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1
por: Shiba, Naoko, et al.
Publicado: (2023) -
Impact of extracellular matrix on engraftment and maturation of pluripotent stem cell-derived cardiomyocytes in a rat myocardial infarct model
por: Ogasawara, Tatsuki, et al.
Publicado: (2017) -
Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy
por: Morita, Yuika, et al.
Publicado: (2022) -
Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
por: Tanosaki, Sho, et al.
Publicado: (2021)